Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Elias

Showing results (421-430 of 475) with videos related to

Pageof 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional studyO Glehen, F Kwiatkowski, P H Sugarbaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> AmplificationSiqing Fu, Shuyang Yao, Yuan Yuan, et al.
Breast Cancer Research : BCR|January 24, 2014
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamideDawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, et al.
NPJ Breast Cancer|October 5, 2024
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancerAnthony D Elias, Alyse W Staley, Monica Fornier, et al.
Journal of the American Heart Association|April 23, 2025
Spectrum of Coronary Artery Involvement With Multisystem Inflammatory Syndrome in Children Versus Kawasaki DiseaseSimon Lee, Ashraf S Harahsheh, Geetha Raghuveer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2021
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1Sant P Chawla, Brian A Van Tine, Seth M Pollack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Phase II study of sorafenib in patients with metastatic or recurrent sarcomasRobert G Maki, David R D'Adamo, Mary L Keohan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue SarcomaChristopher W Ryan, Ofer Merimsky, Mark Agulnik, et al.
Scientific Reports|January 14, 2018
Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese MiceCristobal L Miranda, Lance A Johnson, Oriane de Montgolfier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2021
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0Sara M Tolaney, Elizabeth Garrett-Mayer, Julia White, et al.
Pageof 48

Showing results (421-430 of 475) with videos related to

Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional studyO Glehen, F Kwiatkowski, P H Sugarbaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> AmplificationSiqing Fu, Shuyang Yao, Yuan Yuan, et al.
Breast Cancer Research : BCR|January 24, 2014
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamideDawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, et al.
NPJ Breast Cancer|October 5, 2024
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancerAnthony D Elias, Alyse W Staley, Monica Fornier, et al.
Journal of the American Heart Association|April 23, 2025
Spectrum of Coronary Artery Involvement With Multisystem Inflammatory Syndrome in Children Versus Kawasaki DiseaseSimon Lee, Ashraf S Harahsheh, Geetha Raghuveer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2021
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1Sant P Chawla, Brian A Van Tine, Seth M Pollack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Phase II study of sorafenib in patients with metastatic or recurrent sarcomasRobert G Maki, David R D'Adamo, Mary L Keohan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue SarcomaChristopher W Ryan, Ofer Merimsky, Mark Agulnik, et al.
Scientific Reports|January 14, 2018
Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese MiceCristobal L Miranda, Lance A Johnson, Oriane de Montgolfier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2021
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0Sara M Tolaney, Elizabeth Garrett-Mayer, Julia White, et al.
Pageof 48